HALOZYME THERAPEUTICS, INC. (HALO) Stock buybacks 2017–2025
HALOZYME THERAPEUTICS, INC. (HALO) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$342.4MFY2025 · since FY2017: $0 → $342.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $342.4M | +36.9% |
| FY2024 | $250.0M | -37.9% |
| FY2023 | $402.4M | +101.2% |
| FY2022 | $200.0M | -42.9% |
| FY2021 | $350.1M | +133.2% |
| FY2020 | $150.1M | -24.9% |
| FY2019 | $200.0M | — |
| FY2018 | $0 | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice